Aandelen in “Productie van analytische laboratoriuminstrumenten”

Aandeel Datum Koers Evolutie
vlag Aethlon Medical Inc 1/05 2,300 USD
+3,14% 		+3,14%
vlag Avantor Inc. 1/05 7,960 USD
-1,73% 		-1,73%

Nieuws over “Productie van analytische laboratoriuminstrumenten”

30/04 · Illumina Reports Financial Results for First Quarter of Fiscal Year 2026 · Persbericht

30/04 · Illumina Reports Financial Results for First Quarter of Fiscal Year 2026 · Persbericht

29/04 · Avantor® Reports First Quarter 2026 Results · Persbericht

23/04 · Avantor® Announces Ludovic Brellier as Executive Vice President, Bioscience & Medtech Products (BMP) & Chief Transformation Officer · Persbericht

21/04 · Avantor® Unifies Masterflex® Portfolio to Streamline Fluid Management from R&D to Bioprocess Manufacturing · Persbericht

20/04 · Waters Corporation Schedules First Quarter 2026 Earnings Conference Call · Persbericht

16/04 · DRAGEN v4.5 supports Illumina's new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflows · Persbericht

14/04 · Illumina and the Center for Data-Driven Discovery in Biomedicine bring genomic data and scalable software to the fight against pediatric cancer and rare disease · Persbericht

14/04 · Waters Debuts Industry-First Extended-Range MALS Detector for UHPLC/UPLC, Powering Rapid Characterization of Large Molecules · Persbericht

13/04 · Avantor® Enhances U.S. Biomanufacturing Infrastructure with Expanded Stability and Microbial Testing Facility · Persbericht

9/04 · Illumina to Announce First Quarter 2026 Financial Results on Thursday, April 30, 2026 · Persbericht

8/04 · Waters Announces FDA Clearance of the Most Comprehensive At-Home Cervical Cancer Screening Tool, the Onclarity HPV Self-Collection Kit and FDA-Approved HPV Assay · Persbericht

3/04 · Avantor® to Report First Quarter 2026 Earnings on Wednesday, April 29, 2026 · Persbericht

2/04 · Illumina Announces Changes to Board of Directors · Persbericht

1/04 · Avantor® Announces CFO Transition · Persbericht

25/03 · Dirk Bontridder geeft fakkel door bij Amerikaanse groep PerkinElmer · Tijd.be (€)

De Belgische topmanager Dirk Bontridder is niet langer de CEO van de Amerikaanse groep PerkinElmer, een specialist in allerhande technologie en oplossingen voor metingen, berekeningen, testen en rappo...

24/03 · Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review · Persbericht

18/03 · Illumina and Labcorp expand collaboration to broaden access to precision oncology testing · Persbericht

18/03 · Waters Prices Offering of Senior Notes · Persbericht

16/03 · Illumina advances preventive genomics through strategic consortium with Veritas Genetics · Persbericht

12/03 · Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities · Persbericht

Mijn selecties